PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism (Q36793098)

16 August 2017

PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism (English)

1 reference

secondary hyperparathyroidism

16 August 2017

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Masafumi Fukagawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Shingo Fukuma

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Takeshi Hasegawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

9

M Alan Brookhart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

12

Shunichi Fukuhara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1

Tadao Akizawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

11

Kiyoshi Kurokawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Masahide Mizobuchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Yoshihiro Onishi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Takuhiro Yamaguchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Alan R Ellis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

13 April 2016

1 reference

16 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

19612

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

3 June 2020

copyright license

start time

1 April 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Shorter dialysis times are associated with higher mortality among incident hemodialysis patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Marginal structural models and causal inference in epidemiology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Chronic kidney disease: No significant effect of cinacalcet on cardiovascular outcomes in patients undergoing dialysis--EVOLVE results

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Race is a major determinant of secondary hyperparathyroidism in uremic patients.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Analysis of case-cohort designs

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4829837

Trials in Kidney Disease — Time to EVOLVE

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSREP19612

An international study of patient compliance with hemodialysis

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/27071541

12 December 2020

Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27071541

12 December 2020

Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients: rationale and study design

1 reference

https://pubmed.ncbi.nlm.nih.gov/27071541

12 December 2020

Out-of-pocket spending and medication adherence among dialysis patients in twelve countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/27071541

12 December 2020

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27071541

12 December 2020

Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27071541

12 December 2020

Identifiers

DOI

10.1038/SREP19612

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27071541%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

PubMed publication ID

27071541

1 reference